Diagnosis and Therapy of Myelodysplastic Syndromes in Germany: A Retrospective Multicenter Analysis

Publisher： Karger

E-ISSN： 2296-5262|35|6|350-356

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.35, Iss.6, 2012-05, pp. : 350-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Danazol Therapy for Thrombocytopenia in Patients with Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 107, Iss. 4, 2002-05 ,pp. : 234-236

Karger

Access to resources Recommend Favorite

Immunosuppressive Therapy in Myelodysplastic Syndromes Is Still Alive

By  

Acta Haematologica, Vol. 134, Iss. 3, 2015-04 ,pp. : 135-137

Karger

Access to resources Recommend Favorite

Myelodysplastic Syndromes: Aspects of Current Medical Care and Economic Considerations in Germany

By  

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-07 ,pp. : 477-484

Karger

Access to resources Recommend Favorite

Myelodysplastic syndromes: 2015 Update on diagnosis, risk‐stratification and management

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 831-841

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 6, 2015-06 ,pp. : 463-463

John Wiley & Sons Inc

Access to resources Recommend Favorite